Keratoepithelin suppresses the progression of experimental human neuroblastomas

Détails

ID Serval
serval:BIB_8756BC3E52DE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Keratoepithelin suppresses the progression of experimental human neuroblastomas
Périodique
Cancer Research
Auteur⸱e⸱s
Becker  J., Erdlenbruch  B., Noskova  I., Schramm  A., Aumailley  M., Schorderet  D. F., Schweigerer  L.
ISSN
0008-5472 (Print)
Statut éditorial
Publié
Date de publication
05/2006
Volume
66
Numéro
10
Pages
5314-21
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: May 15
Résumé
Neuroblastoma is the most common extracranial childhood tumor. High expression of activin A is associated with a favorable prognosis, but the contributing mechanisms have remained unclear. Our previous demonstration of the activin A-mediated up-regulation of keratoepithelin led to the consideration that keratoepithelin could modulate neuroblastoma growth and/or progression. We report here that enhanced keratoepithelin expression in human neuroblastoma cells suppresses neuroblastoma cell cohesion and adhesion to various extracellular matrix proteins and that it inhibits neuroblastoma cell proliferation and invasion in vitro and in vivo. Using microarray analysis, we identified several keratoepithelin-regulated genes that may contribute to these biological changes. Together with the observation that keratoepithelin is expressed in human neuroblastomas in vivo, our data suggest that keratoepithelin could play a beneficial role in neuroblastoma development and/or progression.
Mots-clé
Animals Cell Adhesion/physiology Cell Growth Processes/physiology Chick Embryo Disease Progression Extracellular Matrix Proteins/*biosynthesis/genetics Humans Mice Neoplasm Invasiveness Neuroblastoma/genetics/*metabolism/*pathology Transfection Transforming Growth Factor beta/*biosynthesis/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 13:58
Dernière modification de la notice
20/08/2019 15:46
Données d'usage